FRESENUIS KABI
GSK not under compulsion to buy Indian companies: Hasit JoshipuraGSK will not pay exorbitant price to buy Indian companies as it is under no such compulsions, a top company executive said.- Small drug cos on anti-buyout driveConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Small drug firms to seek protectionConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Pharma MNCs will call the shots soonForeign drugmakers are poised to regain the supremacy they ceded during the 1970s, thanks to their strategy of gobbling up India’s leading ...
- MNCs back in control of 50% of Indian pharma marketAcquisitions to help MNCs control nearly 50% of $9.5-billion domestic retail drug market: Analysts
Load More- Pharma MNCs will call the shots soon